Santen Pharmaceutical Co Ltd, a pharmaceutical company based in Japan, with a medium risk rating score based on their ESG score. Specializing in ophthalmic products, Santen focuses on prescription and over-the-counter pharmaceuticals, as well as medical devices. With a strong presence in Japan and other Asian countries, the company's primary revenue comes from their prescription ophthalmic pharmaceuticals segment.